Clinical trial
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I…
NCT00041470 · University of Washington, Other · Terminated
Key facts
| NCT number | NCT00041470 |
|---|---|
| Title | Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial |
| Official title | Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial |
| Lead sponsor | University of Washington, Other |
| Collaborators | Amgen Industry Bristol-Myers Squibb GlaxoSmithKline |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Vinorelbine, Herceptin, Filgrastim |
| Enrollment | 38 |
| Start date | Mar 1, 2001 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jul 10, 2002 |
| Last update posted | Jul 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: